الفهرس 
INTRODUCTION and aim of the workOnly 14 pages are availabe for public view
 |  | from | 171 |  |  |
| | | from | 171 | | |
Abstract
From the above result we concluded that Elevated levels of circulating ICAM -1 may be produced in liver disease in response to hepatic inflammation but this remains speculation. Serum ICAM-1 closely correlated with activity of the disease more than chronicity. Serum ICAM-1 strongly correlate with the degree of activity (grading) more than i~s correlation with degree of fibrosis ( staging). K _ Serum ICAM-1 concentration may represent, at least in part, hepatcellular damage. In the same time sICAM-1 may be used as a useful non invasive indicator of liver cell damage and, to less extent, to suspect the histological graded inflammatory activity in the liver.